Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs. Birth Control Pill in Treating PCOS in Women of Later Reproductive Age
NCT03905941Phase 1Withdrawn
- Sponsor
- University of Virginia
- Start
- Aug 2021
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in polycystic ovary syndrome (PCOS) (2 arms), sponsored by University of Virginia. Primary endpoint: Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire at 12 months. Planned start Aug 2021; status: withdrawn.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT03905941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03905941.